The clinical utility of pleural YKL-40 levels in diagnosing pleural effusions

KAYHAN S., Gumus A. , CINARKA H. , Murat N., Yilmaz A. , Bedir R. , ...Daha Fazla

JOURNAL OF THORACIC DISEASE, cilt.5, sa.5, ss.634-640, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background and objective: Recent evidence suggests that YKL-40 is a relatively new biomarker of inflammation and it is involved in the pathogenesis of several pulmonary diseases. Details of serum and pleural YKL-40 in pleural effusions however, remain unknown. We aimed to assess whether serum and pleural YKL-40 is an accurate biomarker of pleural effusions.